Related references
Note: Only part of the references are listed.Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes
Karama Asleh et al.
NATURE COMMUNICATIONS (2022)
IceR improves proteome coverage and data completeness in global and single-cell proteomics
Mathias Kalxdorf et al.
NATURE COMMUNICATIONS (2021)
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)
Meenakshi Anurag et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer
Amir Sonnenblick et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Microscaled proteogenomic methods for precision oncology
Shankha Satpathy et al.
NATURE COMMUNICATIONS (2020)
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Karsten Krug et al.
CELL (2020)
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
H. Raza Ali et al.
NATURE CANCER (2020)
Boosting to Amplify Signal with Isobaric Labeling (BASIL) Strategy for Comprehensive Quantitative Phosphoproteomic Characterization of Small Populations of Cells
Lian Yi et al.
ANALYTICAL CHEMISTRY (2019)
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Yi-Zhou Jiang et al.
CANCER CELL (2019)
The Case for Proteomics and Phospho-Proteomics in Personalized Cancer Medicine
Sophia Doll et al.
PROTEOMICS CLINICAL APPLICATIONS (2019)
A Multigene Assay Determines Risk of Recurrence in Patients with Triple-Negative Breast Cancer
Rachel L. Stewart et al.
CANCER RESEARCH (2019)
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
Johanna Wagner et al.
CELL (2019)
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
Uku Raudvere et al.
NUCLEIC ACIDS RESEARCH (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Breast cancer quantitative proteome and proteogenomic landscape
Henrik J. Johansson et al.
NATURE COMMUNICATIONS (2019)
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
Michal Harel et al.
CELL (2019)
A Review on Quantitative Multiplexed Proteomics
Nishant Pappireddi et al.
CHEMBIOCHEM (2019)
Single-pot, solid-phase-enhanced sample preparation for proteomics experiments
Christopher S. Hughes et al.
NATURE PROTOCOLS (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Extending the Compatibility of the SP3 Paramagnetic Bead Processing Approach for Proteomics
Sophie Moggridge et al.
JOURNAL OF PROTEOME RESEARCH (2018)
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
Scott J. Rodig et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification
Gali Yanovich et al.
CANCER RESEARCH (2018)
SCoPE-MS: mass spectrometry of single mammalian cells quantifies proteome heterogeneity during cell differentiation
Bogdan Budnik et al.
GENOME BIOLOGY (2018)
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Investigating Acquisition Performance on the Orbitrap Fusion When Using Tandem MS/MS/MS Scanning with Isobaric Tags
Christopher S. Hughes et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Evaluating the Characteristics of Reporter Ion Signal Acquired in the Orbitrap Analyzer for Isobaric Mass Tag Proteome Quantification Experiments
Christopher S. Hughes et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling
In Ah Park et al.
PLOS ONE (2017)
Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors
Martin H. Pedersen et al.
ONCOIMMUNOLOGY (2017)
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer A Secondary Analysis of a Randomized Clinical Trial
Shuzhen Liu et al.
JAMA ONCOLOGY (2017)
Downregulation of TAP1 and TAP2 in early stage breast cancer
Andrea M. Henle et al.
PLOS ONE (2017)
Migrating into the Tumor: a Roadmap for T Cells
Lieke L. van der Woude et al.
TRENDS IN CANCER (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor
Brandon S. Sheffield et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype
Jennifer B. Dennison et al.
CLINICAL CANCER RESEARCH (2016)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Lyndsay N. Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins et al.
NATURE (2016)
Proteomic maps of breast cancer subtypes
Stefka Tyanova et al.
NATURE COMMUNICATIONS (2016)
Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
Ellen Pure et al.
CANCER IMMUNOLOGY RESEARCH (2016)
System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue Homeostasis
Yair Pozniak et al.
CELL SYSTEMS (2016)
Proteomic developments in the analysis of formalin-fixed tissue
Ove J. R. Gustafsson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Brett Wallden et al.
BMC MEDICAL GENOMICS (2015)
Using Peptide-Level Proteomics Data for Detecting Differentially Expressed Proteins
Tomi Suomi et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Unrestricted modification search reveals lysine methylation as major modification induced by tissue formalin fixation and paraffin embedding
Ying Zhang et al.
PROTEOMICS (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
Katherine A. Hoadley et al.
CELL (2014)
Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer
Aleix Prat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Efficient sample processing for proteomics applications-Are we there yet?
Evgeny Kanshin et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
Ultrasensitive proteome analysis using paramagnetic bead technology
Christopher S. Hughes et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
Effect of ASCO/CAP Guidelines for Determining ER Status on Molecular Subtype
Brenda Deyarmin et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Cellular Fatty Acid Metabolism and Cancer
Erin Currie et al.
CELL METABOLISM (2013)
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Laurence Zitvogel et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
Aleix Prat et al.
ONCOLOGIST (2013)
The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap
Matthew J. Ellis et al.
CANCER DISCOVERY (2013)
PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers
Roy R. L. Bastien et al.
BMC MEDICAL GENOMICS (2012)
Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
Takayuki Iwamoto et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer
H. Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
Torsten O. Nielsen et al.
CLINICAL CANCER RESEARCH (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Molecular Mechanisms of IFN-gamma to Up-Regulate MHC Class I Antigen Processing and Presentation
Fang Zhou
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival
Maggie C. U. Cheang et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies
SK Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data
S Monti et al.
MACHINE LEARNING (2003)
The roles of IFNγ in protection against tumor development and cancer immunoediting
H Ikeda et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
